TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 17664851

Group type: EXPERIMENTAL
Intervention: Casein hydrolysate containing Val-Pro-Pro (VPP) and Ile-Pro-Pro (IPP)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 24
Study: 16143741

Group type: EXPERIMENTAL
Intervention: Cocaine exposure
Number of subjects: 717
Study: 12898896

Group type: EXPERIMENTAL
Intervention: Ultrasound (US) examination
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: Computed Tomography (CT) examination
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: Combination of US and CT
Number of subjects: 15
Study: 10340153

Group type: EXPERIMENTAL
Intervention: Active nicotine patch
Number of subjects: 34

Group type: COMPARATOR
Intervention: Placebo patch
Number of subjects: 34
Study: 7588427

Group type: EXPERIMENTAL
Intervention: Hexarelin alone
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Hexarelin + hydrocortisone
Number of subjects: 10

Group type: COMPARATOR
Intervention: Hydrocortisone alone
Number of subjects: 10
Study: 1827451

Group type: EXPERIMENTAL
Intervention: Candoxatril 25 mg every 12 h (group 1)
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Candoxatril 100 mg every 12 h (group 2)
Number of subjects: 16

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 16
Study: 7015141

Group type: EXPERIMENTAL
Intervention: Halsted radical mastectomy
Number of subjects: 701

Group type: COMPARATOR
Intervention: Quadrantectomy with axillary dissection and radiotherapy
Number of subjects: 701
Study: 29485289

Group type: EXPERIMENTAL
Intervention: Community treatment orders
Number of subjects: 5548
Study: 29124549

Group type: EXPERIMENTAL
Intervention: Surgical resection of the primary tumor
Number of subjects: 65543

Group type: EXPERIMENTAL
Intervention: Multi-agent chemotherapy with surgical resection
Number of subjects: 65543

Group type: EXPERIMENTAL
Intervention: Single-agent chemotherapy with surgical resection
Number of subjects: 65543

Group type: EXPERIMENTAL
Intervention: Surgical resection of the primary tumor (multivariate analysis)
Number of subjects: 65543
Study: 27811855

Group type: EXPERIMENTAL
Intervention: Home-based walking exercise training and weekly exercise counseling
Number of subjects: 111

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 111
Study: 24351375

Group type: EXPERIMENTAL
Intervention: Dexmedetomidine 1.2 μg/kg/hr (high dose)
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Dexmedetomidine 0.4 μg/kg/hr (low dose)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Dexmedetomidine (combined high and low dose)
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Dexmedetomidine
Number of subjects: 24
Study: 22811306

Group type: EXPERIMENTAL
Intervention: Oral contraceptive pills
Number of subjects: 42

Group type: EXPERIMENTAL
Intervention: Transdermal contraceptive patches
Number of subjects: 42

Group type: EXPERIMENTAL
Intervention: Contraceptive vaginal rings
Number of subjects: 42
Study: 20553665

Group type: EXPERIMENTAL
Intervention: Alcohol‐associated drink (lager based)
Number of subjects: 45

Group type: COMPARATOR
Intervention: Fruit squash‐flavored drink (nonassociated)
Number of subjects: 45

Group type: COMPARATOR
Intervention: Apple schnapps‐flavored drink (nonassociated)
Number of subjects: 45
Study: 17667333

Group type: EXPERIMENTAL
Intervention: Tenofovir disoproxil fumarate (TDF)
Number of subjects: 154

Group type: EXPERIMENTAL
Intervention: K65R mutation
Number of subjects: 154

Group type: EXPERIMENTAL
Intervention: L74V/I mutation
Number of subjects: 154
Study: 16333174

Group type: EXPERIMENTAL
Intervention: Subtenon anaesthesia
Number of subjects: 168

Group type: COMPARATOR
Intervention: Peribulbar anaesthesia
Number of subjects: 168
Study: 12391059

Group type: EXPERIMENTAL
Intervention: Creatine supplementation (20 g/day for 4 days, then 2 g/day for 17 days)
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Creatine supplementation
Number of subjects: 10

Group type: COMPARATOR
Intervention: Placebo supplementation
Number of subjects: 10
Study: 10608603

Group type: EXPERIMENTAL
Intervention: High intensity (HI, 80% of VO2max, n = 10)
Number of subjects: 26

Group type: EXPERIMENTAL
Intervention: Low intensity (LO, 40% of VO2max, n = 8)
Number of subjects: 26

Group type: COMPARATOR
Intervention: Control (CON, n = 8)
Number of subjects: 26
Study: 7860832

Group type: EXPERIMENTAL
Intervention: Vowel tokens with high goodness ratings from Experiment 1
Number of subjects: 0

Group type: COMPARATOR
Intervention: Vowel tokens with low goodness ratings from Experiment 1
Number of subjects: 0
Study: 2288828

Group type: EXPERIMENTAL
Intervention: Cathinone
Number of subjects: 6

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 6
Study: 7009002

Group type: EXPERIMENTAL
Intervention: Verapamil
Number of subjects: 28

Group type: COMPARATOR
Intervention: Saline
Number of subjects: 28
Study: 31842821

Group type: EXPERIMENTAL
Intervention: Active DLPFC rTMS
Number of subjects: 99

Group type: EXPERIMENTAL
Intervention: Active LPC rTMS
Number of subjects: 99

Group type: COMPARATOR
Intervention: Sham rTMS
Number of subjects: 99
Study: 28483164

Group type: EXPERIMENTAL
Intervention: 2.5% sodium hypochlorite (NaOCl), n = 22
Number of subjects: 43

Group type: COMPARATOR
Intervention: Saline, n = 21
Number of subjects: 43
Study: 25911762

Group type: EXPERIMENTAL
Intervention: Pulsed electric field at Jiaji (EX-B 2) points with optimal prescription: high frequency (10^3 Hz), 0-90 V pulse amplitude, 0.4 ms pulse width, and 5 months treatment time.
Number of subjects: 56
Study: 24231671

Group type: EXPERIMENTAL
Intervention: Arthroscopic rotator cuff repair with AC joint resection
Number of subjects: 40

Group type: COMPARATOR
Intervention: Isolated rotator cuff repair (control group)
Number of subjects: 40
Study: 21340034

Group type: EXPERIMENTAL
Intervention: Theta‐tDCS during NonREM sleep
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Theta‐tDCS during REM sleep
Number of subjects: 0
Study: 19730217

Group type: EXPERIMENTAL
Intervention: Epsilon aminocaproic acid (EACA) 100 mg/kg
Number of subjects: 182

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 182
Study: 16965635

Group type: EXPERIMENTAL
Intervention: Oral dexamethasone 3 mg twice daily for 5 days
Number of subjects: 25

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 25
Study: 11232497

Group type: EXPERIMENTAL
Intervention: Lamivudine monotherapy
Number of subjects: 89

Group type: EXPERIMENTAL
Intervention: Lamivudine withdrawal
Number of subjects: 89
Study: 8646866

Group type: EXPERIMENTAL
Intervention: Fluticasone propionate ointment, 0.005%
Number of subjects: 74

Group type: COMPARATOR
Intervention: Betamethasone-17,21-dipropionate ointment, 0.05%
Number of subjects: 74
Study: 1948104

Group type: EXPERIMENTAL
Intervention: Operative treatment
Number of subjects: 302

Group type: COMPARATOR
Intervention: Conservative treatment
Number of subjects: 302
Study: 6395232

Group type: EXPERIMENTAL
Intervention: Radiotherapy
Number of subjects: 0

Group type: COMPARATOR
Intervention: Surgery
Number of subjects: 0
Study: 31513675

Group type: EXPERIMENTAL
Intervention: Intermittent theta burst stimulation (iTBS)
Number of subjects: 0

Group type: COMPARATOR
Intervention: 10Hz repetitive transcranial magnetic stimulation (rTMS)
Number of subjects: 0
Study: 30412068

Group type: EXPERIMENTAL
Intervention: Pharmacologic agents
Number of subjects: 14139

Group type: EXPERIMENTAL
Intervention: Dexamethasone
Number of subjects: 14139
Study: 27344046

Group type: EXPERIMENTAL
Intervention: Budesonide/formoterol (BF) 320/9 μg delivered by Spiromax
Number of subjects: 16

Group type: COMPARATOR
Intervention: Budesonide/formoterol (BF) 320/9 μg delivered by Turbuhaler
Number of subjects: 16
Study: 25239721

Group type: EXPERIMENTAL
Intervention: Decolonization with nasal mupirocin and chlorhexidine bathing, enhanced environmental cleaning with bleach every 4 months; newly admitted MRSA nares-positive residents decolonized on admission.
Number of subjects: 3

Group type: COMPARATOR
Intervention: Control units screened but not decolonized; received periodic bleach environmental cleaning and instruction on hand hygiene.
Number of subjects: 3

Group type: EXPERIMENTAL
Intervention: All units followed intervention protocol in year 2.
Number of subjects: 3
Study: 22313076

Group type: EXPERIMENTAL
Intervention: Granisetron 10 µg/kg diluted in 10 ml saline 0.9% intravenously (group 1, n=40)
Number of subjects: 80

Group type: COMPARATOR
Intervention: Placebo (10 ml 0.9% saline, group 2, n=40)
Number of subjects: 80
Study: 20002510

Group type: EXPERIMENTAL
Intervention: Adapted U.S. model of pharmaceutical care
Number of subjects: 334

Group type: COMPARATOR
Intervention: Usual care (control)
Number of subjects: 334
Study: 17908628

Group type: EXPERIMENTAL
Intervention: Radiation therapy combined with chemotherapy
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Combined-modality therapy
Number of subjects: 0
Study: 16257339

Group type: EXPERIMENTAL
Intervention: Gefitinib (250 mg/day) plus best supportive care
Number of subjects: 1692

Group type: COMPARATOR
Intervention: Placebo plus best supportive care
Number of subjects: 1692
Study: 11903075

Group type: EXPERIMENTAL
Intervention: Platelet apheresis (c-PRP)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Control group (no apheresis)
Number of subjects: 20
Study: 10103301

Group type: EXPERIMENTAL
Intervention: Dust control intervention (cleaning equipment and up to eight visits by a dust control advisor)
Number of subjects: 275

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 275

Group type: EXPERIMENTAL
Intervention: Dust control intervention
Number of subjects: 275
Study: 7551427

Group type: EXPERIMENTAL
Intervention: Nurse described as 'a good researcher'
Number of subjects: 0

Group type: COMPARATOR
Intervention: Nurse described as 'a good clinician'
Number of subjects: 0
Study: 2200966

Group type: EXPERIMENTAL
Intervention: Corticosteroids (prednisolon 2 mg/kg/day IV initially, then prednisone orally for 3 weeks)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Control (no corticosteroids)
Number of subjects: 60
Study: 30795958

Group type: EXPERIMENTAL
Intervention: Treatment-free follow-up phase after stopping tenofovir disoproxil fumarate therapy
Number of subjects: 124

Group type: EXPERIMENTAL
Intervention: Treatment-free follow-up phase for HBeAg-positive patients
Number of subjects: 124
Study: 28847886

Group type: EXPERIMENTAL
Intervention: Sitagliptin
Number of subjects: 12275
Study: 26346302

Group type: EXPERIMENTAL
Intervention: Food items (fish, pizza, chicken, cereals) and FADS1 rs174546 genotypes used as predictors in mathematical models.
Number of subjects: 1607
Study: 23460845

Group type: EXPERIMENTAL
Intervention: Nintendo® Wii™ training
Number of subjects: 42

Group type: COMPARATOR
Intervention: Control group (no training with the Nintendo® Wii™)
Number of subjects: 42
Study: 22117658

Group type: EXPERIMENTAL
Intervention: Dietary Approaches to Hypertension diet
Number of subjects: 828
Study: 19770624

Group type: EXPERIMENTAL
Intervention: ezetimibe 10 mg daily
Number of subjects: 44

Group type: COMPARATOR
Intervention: placebo
Number of subjects: 44
Study: 17449936

Group type: EXPERIMENTAL
Intervention: Urgent CABG
Number of subjects: 104
Study: 15196292

Group type: EXPERIMENTAL
Intervention: High-dose intravenous eletriptan (n = 24)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Standard dose of sumatriptan (6 mg subcutaneously, n = 18)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Placebo (n = 18)
Number of subjects: 60
Study: 11602853

Group type: EXPERIMENTAL
Intervention: Basiliximab (20 mg, intravenously on days 0 and 4)
Number of subjects: 340

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 340

Group type: EXPERIMENTAL
Intervention: Basiliximab
Number of subjects: 340
Study: 9870123

Group type: EXPERIMENTAL
Intervention: Limited echocardiograms
Number of subjects: 0

Group type: COMPARATOR
Intervention: Standard echocardiograms
Number of subjects: 0
Study: 8078710

Group type: EXPERIMENTAL
Intervention: Iopentol (Imagopaque)
Number of subjects: 59

Group type: COMPARATOR
Intervention: Metrizoate (Isopaque)
Number of subjects: 59
Study: 2576767

Group type: EXPERIMENTAL
Intervention: Ranitidine
Number of subjects: 1012

Group type: EXPERIMENTAL
Intervention: Ranitidine and somatostatin
Number of subjects: 1012

Group type: COMPARATOR
Intervention: Cimetidine
Number of subjects: 1012

Group type: COMPARATOR
Intervention: Anti-acids (first group)
Number of subjects: 1012

Group type: COMPARATOR
Intervention: Anti-acids (second group)
Number of subjects: 1012
Study: 899874

Group type: EXPERIMENTAL
Intervention: Doleron (combination tablet containing propoxyphene chloride, acetyl salicylic acid, and phenazone) taken with a standardized breakfast meal
Number of subjects: 8

Group type: COMPARATOR
Intervention: Doleron (combination tablet containing propoxyphene chloride, acetyl salicylic acid, and phenazone) taken on an empty stomach
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Doleron (combination tablet containing propoxyphene chloride, acetyl salicylic acid, and phenazone)
Number of subjects: 8
Study: 30642320

Group type: EXPERIMENTAL
Intervention: Simulation teaching with standardized patients
Number of subjects: 157

Group type: COMPARATOR
Intervention: Traditional teaching methods
Number of subjects: 157
Study: 28870473

Group type: EXPERIMENTAL
Intervention: Carob snack
Number of subjects: 50

Group type: COMPARATOR
Intervention: Chocolate cookie
Number of subjects: 50
Study: 25575246

Group type: EXPERIMENTAL
Intervention: AeroEclipse II BAN nebulizer with 30-second inhalation
Number of subjects: 32

Group type: COMPARATOR
Intervention: EW nebulizer with 30-second inhalation
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: AeroEclipse II BAN nebulizer with 20-second inhalation
Number of subjects: 32

Group type: COMPARATOR
Intervention: EW nebulizer with 20-second inhalation
Number of subjects: 32
Study: 23512743

Group type: EXPERIMENTAL
Intervention: Diet (D)
Number of subjects: 192

Group type: EXPERIMENTAL
Intervention: Knee-exercise (E)
Number of subjects: 192

Group type: COMPARATOR
Intervention: Control (C)
Number of subjects: 192
Study: 21317179

Group type: EXPERIMENTAL
Intervention: Low-dose CT screening
Number of subjects: 32000

Group type: COMPARATOR
Intervention: No screening
Number of subjects: 32000
Study: 18256842

Group type: EXPERIMENTAL
Intervention: Macugen®
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Lucentis®
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Avastin®
Number of subjects: 0
Study: 16945217

Group type: EXPERIMENTAL
Intervention: Transcranial color-coded ultrasound
Number of subjects: 52

Group type: EXPERIMENTAL
Intervention: Extracranial duplex and Doppler ultrasound
Number of subjects: 52
Study: 14508127

Group type: EXPERIMENTAL
Intervention: Synthetic Porcine Secretin (SPS)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Synthetic Human Secretin (SHS)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Synthetic forms of secretin
Number of subjects: 30

Group type: COMPARATOR
Intervention: Biologic Porcine Secretin (BPS)
Number of subjects: 30
Study: 11155785

Group type: EXPERIMENTAL
Intervention: Brief interventions for problem drinking
Number of subjects: 0
Study: 9126090

Group type: EXPERIMENTAL
Intervention: Li 'no‐scalpel' method
Number of subjects: 256

Group type: COMPARATOR
Intervention: Conventional technique
Number of subjects: 256
Study: 8257225

Group type: EXPERIMENTAL
Intervention: Closed-suction drainage (n = 42)
Number of subjects: 81

Group type: COMPARATOR
Intervention: Nondrainage (n = 39)
Number of subjects: 81

Group type: EXPERIMENTAL
Intervention: Major liver resection (both groups)
Number of subjects: 81

Group type: EXPERIMENTAL
Intervention: Minor liver resection (both groups)
Number of subjects: 81
Study: 3898920

Group type: EXPERIMENTAL
Intervention: Continuous low-dose intravenous infusion of lidocaine (2 mg/kg) for 24 hours after surgery
Number of subjects: 20

Group type: COMPARATOR
Intervention: Saline infusion
Number of subjects: 20
Study: 31767935

Group type: EXPERIMENTAL
Intervention: Rheumatoid arthritis patients
Number of subjects: 31

Group type: COMPARATOR
Intervention: Healthy controls
Number of subjects: 31
Study: 29624641

Group type: EXPERIMENTAL
Intervention: Aerobic training (n=33)
Number of subjects: 65

Group type: COMPARATOR
Intervention: Stretching group (n=32)
Number of subjects: 65
Study: 27626084

Group type: EXPERIMENTAL
Intervention: Auditory lateralization training for 6 weeks (12 sessions)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Control group (no training)
Number of subjects: 60
Study: 24989775

Group type: EXPERIMENTAL
Intervention: GAL-021 at 0.96 mg kg(‐1) h(‐1) for 1 h
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: GAL-021
Number of subjects: 30

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 30
Study: 22527222

Group type: EXPERIMENTAL
Intervention: PAI‐1 4G/5G genotype
Number of subjects: 136

Group type: EXPERIMENTAL
Intervention: Other PAI‐1 genotypes (4G/4G and 5G/5G)
Number of subjects: 136

Group type: EXPERIMENTAL
Intervention: Combination of PAI‐1 variants with known genetic thrombophilias
Number of subjects: 136

Group type: EXPERIMENTAL
Intervention: Prothrombin (G20210A) genotype
Number of subjects: 136
Study: 20129567

Group type: EXPERIMENTAL
Intervention: Percutaneous coronary intervention (PCI)
Number of subjects: 354
Study: 18847647

Group type: EXPERIMENTAL
Intervention: Laparoscopic ileocolic resection (LC)
Number of subjects: 56

Group type: COMPARATOR
Intervention: Open ileocolic resection (OC)
Number of subjects: 56
Study: 15241749

Group type: EXPERIMENTAL
Intervention: Donepezil
Number of subjects: 18

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 18
Study: 12422292

Group type: EXPERIMENTAL
Intervention: Soft-Sense device measuring blood glucose from the forearm
Number of subjects: 66

Group type: EXPERIMENTAL
Intervention: Soft-Sense device measuring blood glucose from the fingertip
Number of subjects: 66
Study: 9649904

Group type: EXPERIMENTAL
Intervention: Quantitative analysis using the least-squares method
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Visual evaluation
Number of subjects: 20

Group type: COMPARATOR
Intervention: Reference values for healthy women
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Segment 3 as a reference
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Three different methods of 'normalization'
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Visual and quantitative analysis agreement
Number of subjects: 20
Study: 7855691

Group type: EXPERIMENTAL
Intervention: 4 mg daily acenocoumarin
Number of subjects: 258

Group type: COMPARATOR
Intervention: 2 mg daily acenocoumarin
Number of subjects: 258
Study: 2766661

Group type: EXPERIMENTAL
Intervention: Potassium canrenoate (100 mg twice daily for 10 days)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Control subjects (no specific intervention mentioned)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Hypertensive patients (after potassium canrenoate administration)
Number of subjects: 20
Study: 948717

Group type: EXPERIMENTAL
Intervention: Irrigation of the vas deferens with 40 ml of sterile water on each side
Number of subjects: 59

Group type: COMPARATOR
Intervention: Control group (no irrigation)
Number of subjects: 59
Study: 31899473

Group type: EXPERIMENTAL
Intervention: Prasugrel
Number of subjects: 90

Group type: COMPARATOR
Intervention: Clopidogrel
Number of subjects: 90

Group type: COMPARATOR
Intervention: Ticagrelor
Number of subjects: 90
Study: 31595565

Group type: EXPERIMENTAL
Intervention: Methazolamide (100 mg twice daily)
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: Acetazolamide (250 mg three times daily)
Number of subjects: 14

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 14
Study: 27806440

Group type: EXPERIMENTAL
Intervention: Left-sided resections
Number of subjects: 94

Group type: COMPARATOR
Intervention: Right-sided resections
Number of subjects: 94
Study: 26689783

Group type: EXPERIMENTAL
Intervention: Rivaroxaban (2.5 mg twice daily)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Rivaroxaban in combination with aspirin plus clopidogrel or with aspirin alone
Number of subjects: 0

Group type: COMPARATOR
Intervention: Standard care (aspirin alone or aspirin and clopidogrel)
Number of subjects: 0
Study: 24699093

Group type: EXPERIMENTAL
Intervention: Gadolinium contrast agent administration
Number of subjects: 20

Group type: COMPARATOR
Intervention: No gadolinium (matched control group)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Gadolinium contrast agent administration (MS group)
Number of subjects: 20
Study: 22563639

Group type: EXPERIMENTAL
Intervention: Acceptance and Commitment Therapy (ACT)
Number of subjects: 128

Group type: COMPARATOR
Intervention: Cognitive Behavioral Therapy (CBT)
Number of subjects: 128

Group type: EXPERIMENTAL
Intervention: Cognitive Behavioral Therapy (CBT) and Acceptance and Commitment Therapy (ACT)
Number of subjects: 128
Study: 20185560

Group type: EXPERIMENTAL
Intervention: 10-day antibiotic therapy
Number of subjects: 0

Group type: COMPARATOR
Intervention: 14-day antibiotic therapy
Number of subjects: 0
Study: 17344356

Group type: COMPARATOR
Intervention: Placebo group
Number of subjects: 126
Study: 16039370

Group type: EXPERIMENTAL
Intervention: Open reduction and internal fixation with dorsal plating
Number of subjects: 0

Group type: COMPARATOR
Intervention: External fixation with K-wires and mini-open reduction
Number of subjects: 0
Study: 11507925

Group type: EXPERIMENTAL
Intervention: Sodium hexametaphosphate-containing dentifrice
Number of subjects: 94

Group type: EXPERIMENTAL
Intervention: Alumina-based high abrasive dentifrice
Number of subjects: 94

Group type: COMPARATOR
Intervention: Lower abrasive control dentifrice
Number of subjects: 94
Study: 10327902

Group type: EXPERIMENTAL
Intervention: Olanzapine (10 mg, adjustable from 5 mg to 20 mg)
Number of subjects: 139

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 139

Group type: EXPERIMENTAL
Intervention: Olanzapine
Number of subjects: 139
Study: 7492113

Group type: EXPERIMENTAL
Intervention: Quinine plus clindamycin
Number of subjects: 100

Group type: COMPARATOR
Intervention: Quinine
Number of subjects: 100
Study: 1759540

Group type: EXPERIMENTAL
Intervention: Pyridostigmine + GH + GHRH
Number of subjects: 20

Group type: COMPARATOR
Intervention: GH + GHRH
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Pyridostigmine + GH + GHRH in group B
Number of subjects: 20

Group type: COMPARATOR
Intervention: GH + GHRH in group A
Number of subjects: 20

Group type: COMPARATOR
Intervention: GH + GHRH in group B
Number of subjects: 20
Study: 6274471

Group type: EXPERIMENTAL
Intervention: suloctidil 300 mg per day
Number of subjects: 40

Group type: COMPARATOR
Intervention: placebo
Number of subjects: 40
Study: 30756475

Group type: EXPERIMENTAL
Intervention: Fampridine
Number of subjects: 23

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 23